Prior to the pandemic, our interaction with customers was characterized by on-site visits, personal contacts for site qualifications and investigator meetings. In this way, we had the opportunity to engage with our clinical partners right from beginning which is helpful for the future collaboration.
Due to the travel restrictions caused by the pandemic, all that was suddenly no longer possible, we were not able to meet our study partners in person. Especially those sites who were in critical areas like Italy, Spain and France. In addition, the clinics re-prioritized surgeries and clinical studies which had an impact on our investigations.